Toxicology
Alcohols
Coralic Z, Kapur J, Olson KR, Chamberlain JM, Overbeek
D, Silbergleit R. Treatment of toxin-related status epi-
lepticus with levetiracetam, fosphenytoin, or valproate
in patients enrolled in the established status epilepticus
https://doi.org/10.1016/j.annemergmed.2022.04.020
Kruse JA. Methanol and ethylene glycol intoxica-
org/10.1016/j.ccc.2012.07.002
Lao YE, Vartdal T, Froeyshov S, et al. Fomepizole dosing
during continuous renal replacement therapy—an obser-
vational study. Clin Toxicol (Phila). 2022;60(4):451-457.
https://doi.org/10.1080/15563650.2021.1980581
Lepik KJ, Levy AR, Sobolev BG, et al. Adverse drug
events associated with the antidotes for methanol and
ethylene glycol poisoning: a comparison of ethanol and
https://doi.org/10.1016/j.annemergmed.2008.05.008
Marraffa J, Forrest A, Grant W, Stork C, McMartin K,
Howland MA. Oral administration of fomepizole pro-
duces similar blood levels as identical intravenous dose.
Clin Toxicol (Phila). 2008;46(3):181-186. https://doi.
org/10.1080/15563650701373796
Sandor P, Sellers EM, Dumbrell M, Khouw V. Effect
of short- and long-term alcohol use on phenytoin
kinetics in chronic alcoholics. Clin Pharmacol Ther.
1981;30(3):390-397. https://doi.org/10.1038/clpt.1981.178
Alcohol Withdrawal
ASAM clinical practice guideline on alcohol withdrawal
management. J Addict Med. 2020;14(3S suppl 1):1-72.
https://doi.org/10.1097/adm.0000000000000668
Flannery AH, Adkins DA, Cook AM. Unpeeling the
evidence for the banana bag: evidence-based recom-
mendations for the management of alcohol-associated
vitamin and electrolyte deficiencies in the ICU. Crit
ccm.0000000000001659
Leung JG, Hall-Flavin D, Nelson S, Schmidt KA,
Schak KM. The role of gabapentin in the manage-
ment of alcohol withdrawal and dependence. Ann
2015;49(8):897-906.
https://doi.
org/10.1177/1060028015585849
Maldonado JR, Sher Y, Ashouri JF, et al. The “Prediction
of Alcohol Withdrawal Severity Scale” (PAWSS):
systematic literature review and pilot study of a new
scale for the prediction of complicated alcohol with-
drawal syndrome. Alcohol. 2014;48(4):375-390. https://
doi.org/10.1016/j.alcohol.2014.01.004
Pizon AF, Lynch MJ, Benedict NJ, et al. Adjunct
ketamine use in the management of severe ethanol with-
org/10.1097/ccm.0000000000003204
Pourmand A, AlRemeithi R, Kartiko S, Bronstein D,
Tran QK. Evaluation of phenobarbital based approach
in treating patient with alcohol withdrawal syn-
Emerg Med. 2023;69:65-75. https://doi.org/10.1016/j.
ajem.2023.04.002
Sarff M, Gold JA. Alcohol withdrawal syndromes in the
S501. https://doi.org/10.1097/ccm.0b013e3181ec5412
Schuckit MA. Recognition and management of with-
drawal delirium (delirium tremens). N Engl J Med.
2014;371(22):2109-2113.
https://doi.org/10.1056/
nejmra1407298
Stehman CR, Mycyk MB. A rational approach to the
Med.
2013;31(4):734-742.
https://doi.org/10.1016/j.
ajem.2012.12.029
Cardiovascular Agents
American College of Medical Toxicology. ACMT posi-
tion statement: guidance for the use of intravenous lipid
emulsion. J Med Toxicol. 2017;13(1):124-125. https://doi.
org/10.1007/s13181-016-0550-z
Cao D, Heard K, Foran M, Koyfman A. Intravenous lipid
emulsion in the emergency department: a systematic
review of recent literature. J Emerg Med. 2015;48(3):387-
397. https://doi.org/10.1016/j.jemermed.2014.10.009
Engebretsen KM, Kaczmarek KM, Morgan J, Holger
JS. High-dose insulin therapy in beta-blocker and cal-
cium channel-blocker poisoning. Clin Toxicol (Phila).
2011;49(4):277-283. https://doi.org/10.3109/15563650.20
11.582471
Lavonas EJ, Akpunonu PD, Arens AM, et al. 2023
American Heart Association focused update on the man-
agement of patients with cardiac arrest or life-threatening
toxicity due to poisoning: an update to the American
Heart Association Guidelines for Cardiopulmonary
Resuscitation and Emergency Cardiovascular Care.